Vocal Biomarkers Market Analysis 2019 Key News by Top Companies with Latest Technology, Developments, Revenue, Size and Industry Growth Insights to 2023
Market Research Future published a research report on Vocal
Biomarkers Market Research Report- Global Forecast till 2023. Report gives a
clear picture of current market scenario which includes past and estimated
future market size. The report provides detail information and strategies of
top key players in the industry. The report also gives a broad study about
different markets segments and regions.
The
vocal biomarkers market is chiefly driven by rise in cases of psychological,
neurological and other diseases affecting speech such as depression, Attention
Deficit and Disruptive Behavior Disorders, Parkinson's disease (PD),
Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular
Disorders, traumatic brain injury (TBI) etc. According to WHO estimates, around
350 million individuals were suffering from depression in 2016 while the
Parkinson’s disease Foundation, estimated about 10 million individuals
Parkinson’s patients globally in 2016. Thus growing global disease prevalence
will drive vocal biomarkers market size in the coming years. Another potential
area of application is the use of voice biomarkers to detect disorders in
employees and soldiers. For example, the U.S. Army entered into collaboration
with MIT researchers to develop voice biomarkers technology for traumatic brain
injury. American Heart Association in collaboration with Beyond Verbal and Mayo
Clinic has developed artificial intelligence (AI) algorithms by using
machine-learning to perceive voice patterns imperceptible to human ear for
initial identification of coronary heart disease.
The
increasing penetration of mobile technology and information technology is
driving the market. The development of wearable’s coupled with the rising
quality and bandwidth availability is another boon for the market for vocal biomarkers.
Product development is an important strategy and the increasing collaboration
between technology companies and research institutes will yield multiple
benefits to both partners. For example, Sonde Health Inc., has developed a
voice-based technology platform for monitoring and diagnosing diseases and
conditions, has collaborated and licensed the technology from the Massachusetts
Institute of Technology (MIT). Another company Beyond Verbal has developed
vocal biomarket application for detecting emotions. The emotional analysis uses
voice biomarkers to detect the moods such as arousal, temper etc. Beyond Verbal
has also pursued the partnership strategy with Mayo Clinic, Tel Aviv University
and others for the development of vocal biomarkers.
Global
Vocal biomarkers Market Players:
Key
players profiled in the report are Beyond Verbal, Sonde Health, Audio
Profiling, IBM Corporation, Cogito Corporation and others.
Taste
the market data and market information presented through more than 50 market
data tables and figures spread over 80 pages of the project report. Avail the
in-depth table of content (TOC) & market synopsis on “Global Vocal
biomarkers Market” Research Report – Forecast to 2023.
Vocal Biomarkers Market information: by
type (frequency, amplitude, error rate, vocal rise or fall time, phonation
time, voice tremor, pitch, others) by indications (psychiatric disorders
(depression, Attention Deficit and Disruptive Behavior Disorders, others),
neurological disorders (Parkinson's disease (PD), Alzheimer's disease,
Huntington's disease, others), Respiratory Disorders, Cardiovascular Disorders,
traumatic brain injury (TBI), others), others) by end users (hospitals and
clinics, academic and research, others) -Global Forecast till 2023 @https://www.marketresearchfuture.com/reports/vocal-biomarkers-market-3933
Segmentation:
The
global vocal biomarkers market is segmented on the basis of type, indications
and end users. Based on type the market has been segmented as frequency,
amplitude, error rate, vocal rise or fall time, phonation time, voice tremor,
pitch and others. Based on the indications, the market has been segmented as
psychiatric disorders (depression, attention deficit and disruptive behavior
disorders, others), neurological disorders (Parkinson’s disease (PD),
Alzheimer's disease, Huntington's disease, others), respiratory disorders,
cardiovascular disorders, traumatic brain injury (TBI), others) and others.
Based on end users, the market has been segmented as hospitals and clinics,
academic and research and others.
Active
B12 Test Market - Global Forecast Till 2023
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services
Contact:
Market Research
Future
+1 646 845 9312
Comments
Post a Comment